Lavaca Capital’s Biogen BIIB Stock Holding History

Lavaca Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$81.9K	Hold	447	–	–	0.01%	137
2025 Q4	$78.7K	Hold	447	–	–	0.01%	139
2025 Q3	$62.6K	Hold	447	–	–	0.01%	149
2025 Q2	$56.1K	Buy	447 +162	+57%	+$20.2K	0.02%	159
2025 Q1	$39K	Buy	285 +257	+918%	+$36.7K	0.02%	169
2024 Q4	$4.28K	Buy	+28	New	+$4.72K	﹤0.01%	289
2023 Q4	–	Sell	-1,434	Closed	-$369K	–	96
2023 Q3	$369K	Sell	1,434 -17	-1%	-$4.55K	0.12%	118
2023 Q2	$413K	Buy	1,451 +89	+7%	+$26.5K	0.12%	116
2023 Q1	$379K	Sell	1,362 -114	-8%	-$31.5K	0.08%	143
2022 Q4	$409K	Sell	1,476 -95	-6%	-$26.8K	0.13%	132
2022 Q3	$418K	Sell	1,571 -5	-0.3%	-$1.06K	0.15%	106
2022 Q2	$322K	Buy	1,576 +41	+3%	+$8.38K	0.05%	139
2022 Q1	$323K	Buy	+1,535	New	+$334K	0.03%	161
2019 Q2	–	Sell	-45	Closed	-$11K	–	120
2019 Q1	$11K	Hold	45	–	–	0.01%	260
2018 Q4	$14K	Buy	+45	New	+$14.4K	0.01%	207

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lavaca Capital's BIIB Position: Q1 2026 in Review

Lavaca Capital held its Biogen (BIIB) position steady in Q1 2026 at 447 shares worth $81.9K. The position accounts for 0.01% of the portfolio, ranked #137.

Lavaca Capital first reported a position in BIIB in Q4 2018 and has held it in 15 quarters since. The position peaked at $418K in Q3 2022. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Lavaca Capital held 447 shares of Biogen worth $81.9K as of Q1 2026.
Lavaca Capital left its Biogen share count unchanged in Q1 2026.
Biogen made up 0.01% of Lavaca Capital's portfolio in Q1 2026, its #137 holding.
Lavaca Capital first reported a position in Biogen in Q4 2018 and has held it in 15 quarters since.
Lavaca Capital's Biogen position peaked at $418K in Q3 2022.
1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.